tiprankstipranks
Clarity Pharmaceuticals Ltd. (AU:CU6)
ASX:CU6
Australian Market

Clarity Pharmaceuticals Ltd. (CU6) Financial Statements

33 Followers

Clarity Pharmaceuticals Ltd. Financial Overview

Clarity Pharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.116; its P/E ratio is -25.79; Clarity Pharmaceuticals Ltd. is scheduled to report earnings on August 21, 2024, and the estimated EPS forecast is AU$-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22
Income Statement-
Total Revenue-
Gross Profit-
EBIT-
EBITDA-
Net Income Common Stockholders-
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 92.34M
Total AssetsAU$ 99.82M
Total DebtAU$ 0.00
Net DebtAU$ -92.34M
Total LiabilitiesAU$ 7.59M
Stockholders EquityAU$ 92.24M
Cash Flow-
Free Cash Flow-
Operating Cash Flow-
Investing Cash Flow-
Financing Cash Flow-
Currency in AUD

Clarity Pharmaceuticals Ltd. Earnings and Revenue History

Clarity Pharmaceuticals Ltd. Debt to Assets

Clarity Pharmaceuticals Ltd. Cash Flow

Clarity Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis